Kazazian Asset Management, LLC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 63 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
Kazazian Asset Management, LLC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$35,000
-77.1%
11,703
-37.7%
0.05%
-67.1%
Q3 2018$153,000
-16.4%
18,7920.0%0.14%
-14.9%
Q2 2018$183,00018,7920.17%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Prentice Capital Management, LP 390,381$1,292,0000.49%
ETF MANAGERS GROUP, LLC 891,025$2,949,0000.09%
AdvisorShares Investments LLC 353,009$1,168,0000.06%
ALGERT GLOBAL LLC 51,028$169,0000.05%
Bernardo Wealth Planning LLC 27,219$90,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 31,552$104,0000.03%
ZEKE CAPITAL ADVISORS, LLC 49,700$165,0000.02%
Walleye Capital LLC 51,554$171,0000.02%
Dynamic Technology Lab Private Ltd 19,021$63,0000.01%
J.W. COLE ADVISORS, INC. 37,064$123,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders